New agonist of β2-adrenoceptors improves lung function in model of COPD
March 21, 2024
Researchers from Shenyang Pharmaceutical University have discovered novel β2-adrenoceptor (β2-AR) agonists for the treatment of chronic obstructive pulmonary disease (COPD).